Health · Planned · 5 sources combined
Domestic obesity drug 'Epe'
priced at around 130,000 won monthly
In short
Hanmi Pharmaceutical's domestic obesity drug 'Epe' is expected to launch in October.
First-month treatment cost is approximately 130,000 won, about half the price of Mounjaro.
Epe starts at 2mg and increases dosage every two weeks.
Key facts
| When | On October 14th, supply prices for different dosages of Epe were announced in the pharmaceutical industry. |
|---|---|
| Who | It is 'Epe' (epeglenatyide), a domestic GLP-1 obesity treatment drug developed by Hanmi Pharmaceutical. |
| What | First-month medication cost is 129,800 won, and maintenance cost from the fourth month is 299,200 won. |
| How | It starts at 2mg and increases stepwise to 4mg, 6mg, 8mg, and 10mg at two-week intervals. |
What it means for me
Patients considering obesity treatment now have a more affordable option compared to existing imported drugs.
For working adults considering weight management treatment, the financial burden may be reduced.
